BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37622034)

  • 1. Comparison of Different Antibiotics and the Risk for Community-Associated
    Miller AC; Arakkal AT; Sewell DK; Segre AM; Tholany J; Polgreen PM;
    Open Forum Infect Dis; 2023 Aug; 10(8):ofad413. PubMed ID: 37622034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic-Specific Risk for Community-Acquired
    Zhang J; Chen L; Gomez-Simmonds A; Yin MT; Freedberg DE
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0112922. PubMed ID: 36377887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network.
    Rhea S; Jones K; Endres-Dighe S; Munoz B; Weber DJ; Hilscher R; MacFarquhar J; Sickbert-Bennett E; DiBiase L; Marx A; Rineer J; Lewis J; Bobashev G;
    PLoS One; 2020; 15(6):e0234031. PubMed ID: 32525887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
    Tydeman F; Craine N; Kavanagh K; Adams H; Reynolds R; McClure V; Hughes H; Hickman M; Robertson C
    J Antimicrob Chemother; 2021 Aug; 76(9):2437-2445. PubMed ID: 34151964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual effect of community antimicrobial exposure on risk of hospital onset healthcare-associated Clostridioides difficile infection: a case-control study using national linked data.
    Pan J; Kavanagh K; Marwick C; Davey P; Wuiff C; Bryson S; Robertson C; Bennie M
    J Hosp Infect; 2019 Nov; 103(3):259-267. PubMed ID: 31173780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update.
    Slimings C; Riley TV
    J Antimicrob Chemother; 2021 Jun; 76(7):1676-1688. PubMed ID: 33787887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for Clostridioides difficile Infection Among Hospitalized Patients Associated With Multiple Healthcare Exposures Prior to Admission.
    Miller AC; Sewell DK; Segre AM; Pemmaraju SV; Polgreen PM
    J Infect Dis; 2021 Aug; 224(4):684-694. PubMed ID: 33340038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing risk of
    Ge IY; Fevrier HB; Conell C; Kheraj MN; Flint AC; Smith DS; Herrinton LJ
    Ther Adv Urol; 2018 Oct; 10(10):283-293. PubMed ID: 30186366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and
    Vintila BI; Arseniu AM; Morgovan C; Butuca A; Bîrluțiu V; Dobrea CM; Rus LL; Ghibu S; Bereanu AS; Arseniu R; Roxana Codru I; Sava M; Gabriela Gligor F
    Antibiotics (Basel); 2024 Feb; 13(2):. PubMed ID: 38391530
    [No Abstract]   [Full Text] [Related]  

  • 13. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
    Marwick CA; Yu N; Lockhart MC; McGuigan CC; Wiuff C; Davey PG; Donnan PT
    J Antimicrob Chemother; 2013 Dec; 68(12):2927-33. PubMed ID: 23825381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Community-Associated Clostridium difficile Infection in Children.
    Adams DJ; Eberly MD; Rajnik M; Nylund CM
    J Pediatr; 2017 Jul; 186():105-109. PubMed ID: 28396027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia.
    Rhodes NJ; Jozefczyk CC; Moore WJ; Yarnold PR; Harkabuz K; Maxwell R; Sutton SH; Silkaitis C; Qi C; Wunderink RG; Zembower TR
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0041721. PubMed ID: 33875439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis.
    Deshpande A; Pasupuleti V; Thota P; Pant C; Rolston DD; Sferra TJ; Hernandez AV; Donskey CJ
    J Antimicrob Chemother; 2013 Sep; 68(9):1951-61. PubMed ID: 23620467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
    Nelson RL; Suda KJ; Evans CT
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004610. PubMed ID: 28257555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Clostridioides difficile recurrence across a national cohort of veterans in outpatient, acute, and long-term care settings.
    Appaneal HJ; Caffrey AR; Beganovic M; Avramovic S; LaPlante KL
    Am J Health Syst Pharm; 2019 Apr; 76(9):581-590. PubMed ID: 31361830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Primary
    Davies K; Lawrence J; Berry C; Davis G; Yu H; Cai B; Gonzalez E; Prantner I; Kurcz A; Macovei I; Pituch H; Nováková E; Nyč O; Gärtner B; Berger FK; Oleastro M; Cornely OA; Vehreschild MJGT; Pedneault L; Wilcox M
    Front Public Health; 2020; 8():293. PubMed ID: 32766196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.